Biodeal Pharmaceuticals
Ahmedabad, India· Est.
India‑based WHO‑GMP CDMO delivering small‑molecule and nasal‑spray formulations for global pharma partners.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
India‑based WHO‑GMP CDMO delivering small‑molecule and nasal‑spray formulations for global pharma partners.
General MedicineNasal DeliveryNutraceuticalsHerbal/AYUSH
Technology Platform
WHO‑GMP certified manufacturing platform with capabilities in solid‑dose, nasal spray, nutraceutical and herbal formulations, supported by PIC/S and other regulatory approvals.
Opportunities
Rising global demand for outsourced manufacturing, especially in nasal‑spray delivery and nutraceuticals, offers Biodeal opportunities to expand its client base and enter new geographic markets.
Risk Factors
Dependence on contract volumes, stringent regulatory compliance, and intense competition from larger Indian CDMOs could pressure margins and growth.
Competitive Landscape
Competes with Indian CDMOs such as Piramal Pharma Solutions, Suven Pharmaceuticals, and Aurobindo Pharma; differentiation stems from niche nasal‑spray expertise and a strong nutraceutical/AYUSH portfolio.